Patrick Finn
Company: Moderna
Job title: Senior Director - Rare Diseases
Seminars:
Strategies of mRNA- Based Therapeutics to Replace Enzymes for Rare Diseases 3:00 pm
day: Day Two
Strategies of mRNA- Based Therapeutics to Replace Enzymes for Rare Diseases 3:00 pm
Exploring mRNA construct requirements to meet therapeutic thresholds for rare diseases Unravelling the challenges expression vs delivery for successful mtranslation of mRNA- based therapeutics How to predict efficacy from pre-clinical models to unleash the therapeutic benefit for patients with rare diseases?Read more
day: Day Two